CABA: Cabaletta Bio Inc. Kompaniya qiymatining sof foydaga nisbati
Cabaletta Bio, Inc. (CABA) uchun narxlar grafigi -1.70 miqdoridagi PE koeffitsiyentini ko'rsatmoqda. Narxlar dinamikasi klinik sinovlar natijalari bilan boshqariladi, mavjud mablag'lar esa joriy ishlab chiqish dasturlarini yakunlash uchun yetarli. Aksiyaning o'sishi lupus terapiyasining samaradorligi va CARTA hujayralari uchun ommaviy ishlab chiqarishni yo'lga qo'yish bilan bog'liq. Kelajakka nazar tashlab, ushbu metodni patentlash global bozorga chiqishni va past xarajatlar bilan yuqori daromadlilikni ta'minlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_CABA_-_Cabaletta-Bio-Inc._-_PE-Multiple "CABA: Cabaletta Bio, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Cabaletta Bio, Inc (CABA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Cabaletta Bio, Inc.|CABA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Cabaletta Bio Inc|CABA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Cabaletta Bio|CABA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Cabaletta Bio, Inc.|Tezkor likvidlik ko‘rsatkichi cabalettabio.com
- foyda va bozor multiplikatorlari tafsilotlari:
CABA - Sof foyda|Prognoz qilingan kelajakdagi foyda Cabaletta Bio, Inc.|CABA - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Cabaletta Bio Inc.|CABA - PEG multiplikatori|EV/EBITDA multiplikatori Cabaletta Bio|CABA - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Cabaletta Bio, Inc.|CABA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi cabalettabio.com|CABA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Cabaletta Bio, Inc.
Kompaniyaning har tomonlama tahlili:cabalettabio.com CABA
P/E koeffitsiyenti foydaning bitta birligining bozor qiymatini o'lchaydi va investor kelajakdagi daromadlar uchun qanchalik ortiqcha to'lov qilayotganini aniqlaydi. Ushbu metrika joriy narx va biznesning fundamental daromadliligi o'rtasidagi muvozanatni aks ettiradi. Kompaniyaning bozor P/E koeffitsiyentini tahlil qilish orqali aktivlarning adolatli baholanish zonalarini aniqlash mumkin. Cabaletta Bio, Inc. (CABA) uchun ushbu ko'rsatkich iqtisodiy sikllarga emas, balki immunoterapiyadagi klinik ma'lumotlarning istiqbollariga bog'liq.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Tourmaline (TRML) - Narx-foyda koeffitsiyenti|PGEN: P/E multiplikatori|pharming.com (PHAR) - P/E multiplikatori|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Narxning foydaga nisbati UPB|P/E multiplikatori ZBIO|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|kalvista.com - Narxning foydaga nisbati|Septerna - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Pieris Pharma|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|RIGL: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti ANAB|ATXS (astriatx.com) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ENGN|P/E multiplikatori RAPT Therapeutics Inc. (RAPT)|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics - P/E multiplikatori|TLSA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Avalo Therapeutics Inc.|Kapitalizatsiyaning foydaga nisbati Eledon Pharmaceuticals, Inc ELDN|Narx-foyda koeffitsiyenti AGEN (Agenus)|CLYM (climbbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|Biznesning o‘zini qoplash muddati aTyr Pharma Inc (ATYR)|ADAG - Narxning foydaga nisbati|IMA (ImageneBio Inc) - Narx-foyda multiplikatori|STTK: P/E multiplikatori|Narx-foyda koeffitsiyenti Equillium|Narx-foyda koeffitsiyenti CNTB|Immunic Inc (IMUX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ATRA|Narx-foyda koeffitsiyenti inflarx.de IFRX|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|Celularity Corp - P/E multiplikatori|INMB: Narxning foydaga nisbati|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|akaritx.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ENLV|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narx-foyda koeffitsiyenti CALI|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning foydaga nisbati|Ocean Biomedical - P/E multiplikatori|TC BioPharm (Holdings) Plc (TCBP) - Narx-foyda koeffitsiyenti|THRD: P/E multiplikatori
